Forbes 2026 Cannabis 42.0 List

Every April 20, the high holiday for marijuana lovers, is a reason to examine the state of the $30 billion cannabis industry. And this year, there is tremendous optimism that federal reform is finally coming.

In December 2025, President Trump signed an executive order asking the Department of Justice to finish the process to reschedule marijuana as a less dangerous drug. While the $30 billion industry has been anxiously waiting progress since then, President Trump recently fired U.S. Attorney General Pam Bondi, who would have carried out that order. Still, there is hope that the Trump Administration will finish the job and downgrade cannabis from a Schedule I drug—along with heroin and LSD—to a Schedule III substance, along with ketamine and steroids.

On the other hand, marijuana’s cousin, THC-derived from hemp, which has blossomed into a $28 billion industry, is under threat. Last year, an amendment inside the Agriculture Appropriations section of the omnibus spending bill to re-open the federal government after the longest shut down in history, effectively banned most hemp derived-THC products currently on the market, which has been both a lifeline to the struggling marijuana industry and another fierce competitor. If nothing changes, the ban will go into effect in November, and the hemp-derived THC economy will go up in smoke. But hemp companies (and their lobbyists) are working hard to convince lawmakers to prevent the ban from going in place this fall, while others are lobbying for regulations to keep the market alive.

Despite the political whiplash, marijuana and hemp are more mainstream than ever. Medical marijuana sales are legal across 40 states, and 25 have recreational sales, and 88% of Americans believe weed should be legal for medical or recreational use, according to Pew Research Center. And THC beverages are being sold in liquor stores, bars, grocery stores and even retailers like Target.

For the fifth-annual Cannabis 42.0 list, Forbes is celebrating the entrepreneurs, innovators and disruptors who are finding success in the state-regulated cannabis market in spite of these headwinds. Over the last few months, Forbes interviewed dozens of investors, executives, analysts and business owners, studied sales data and financial documents and reviewed nearly 200 applicants to identify the 42 leaders who are transforming cannabis from a criminal enterprise into a robust legal industry. The list is focused on entrepreneurial brands and people revolutionizing the industry from the ground up. Here are the pot pioneers blazing a path forward in 2026.